The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL (vol 33, pg 319, 2019)

被引：1

作者：

Kampen, Kim R. ^{[1
,2
]}

Sulima, Sergey O. ^{[1
,2
]}

Verbelen, Benno ^{[1
,2
]}

Girardi, Tiziana ^{[1
,2
]}

Vereecke, Stijn ^{[1
,2
]}

Fancello, Laura ^{[1
,2
]}

Rinaldi, Gianmarco ^{[2
,3
,4
]}

Verbeeck, Jelle ^{[1
,2
]}

Op de Beeck, Joyce ^{[1
,2
]}

Uyttebroeck, Anne ^{[5
]}

Meijerink, Jules P. P. ^{[6
]}

Moorman, Anthony V. ^{[7
]}

Harrison, Christine J. ^{[7
]}

Spincemaille, Pieter ^{[8
,9
]}

Cools, Jan ^{[2
,10
,11
]}

Cassiman, David ^{[8
,9
]}

Fendt, Sarah-Maria ^{[2
,3
,4
]}

Vermeersch, Pieter ^{[12
]}

De Keersmaecker, Kim ^{[1
,2
]}

机构：

[1] Katholieke Univ Leuven, Lab Dis Mech Canc, Dept Oncol, Leuven, Belgium

[2] Leuven Canc Inst LKI, Leuven, Belgium

[3] VIB, Ctr Canc Biol, Lab Cellular Metab & Metab Regulat, Leuven, Belgium

[4] Katholieke Univ Leuven, Lab Cellular Metab & Metab Regulat, Dept Oncol, Leuven, Belgium

[5] Univ Hosp Leuven, Dept Pediat Oncol & Hematol, Leuven, Belgium

[6] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands

[7] Newcastle Univ, Northern Inst Canc Res, Leukaemia Res Cytogenet Grp, Newcastle Upon Tyne, Tyne & Wear, England

[8] Univ Hosp Leuven, Dept Gastroenterol Hepatol, Leuven, Belgium

[9] Univ Hosp Leuven, Metab Ctr, Leuven, Belgium

[10] Katholieke Univ Leuven, Ctr Human Genet, Lab Mol Biol Leukemia, Leuven, Belgium

[11] VIB, Ctr Canc Biol, Lab Mol Biol Leukemia, Leuven, Belgium

[12] Univ Hosp Leuven, Dept Lab Med, Leuven, Belgium

来源：

LEUKEMIA | 2019年 / 33卷 / 04期

关键词：

D O I：

10.1038/s41375-019-0424-x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Following the publication of this article, the authors noted that Dr Laura Fancello was not listed among the authors. The corrected author list is given below. Additionally, the following was not included in the author contribution statement: ‘L.F. analyzed RNA sequencing data’.

引用

页码：1055 / 1055

页数：1

共 8 条

[1] The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL
Kampen, Kim R.
Sulima, Sergey O.
Verbelen, Benno
Girardi, Tiziana
Vereecke, Stijn
Rinaldi, Gianmarco
Verbeeck, Jelle
Op de Beeck, Joyce
Uyttebroeck, Anne
Meijerink, Jules P. P.
Moorman, Anthony V.
Harrison, Christine J.
Spincemaille, Pieter
Cools, Jan
Cassiman, David
Fendt, Sarah-Maria
Vermeersch, Pieter
De Keersmaecker, Kim
LEUKEMIA, 2019, 33 (02) : 319 - 332
[2] The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL
Kim R. Kampen
Sergey O. Sulima
Benno Verbelen
Tiziana Girardi
Stijn Vereecke
Gianmarco Rinaldi
Jelle Verbeeck
Joyce Op de Beeck
Anne Uyttebroeck
Jules P. P. Meijerink
Anthony V. Moorman
Christine J. Harrison
Pieter Spincemaille
Jan Cools
David Cassiman
Sarah-Maria Fendt
Pieter Vermeersch
Kim De Keersmaecker
Leukemia, 2019, 33 : 319 - 332
[3] Correction: The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL
Kim R. Kampen
Sergey O. Sulima
Benno Verbelen
Tiziana Girardi
Stijn Vereecke
Laura Fancello
Gianmarco Rinaldi
Jelle Verbeeck
Joyce Op de Beeck
Anne Uyttebroeck
Jules P. P. Meijerink
Anthony V. Moorman
Christine J. Harrison
Pieter Spincemaille
Jan Cools
David Cassiman
Sarah-Maria Fendt
Pieter Vermeersch
Kim De Keersmaecker
Leukemia, 2019, 33 : 1055 - 1062
[4] BCL-2 INHIBITION AS NEW THERAPEUTIC OPPORTUNITY FOR RPL10 R98S MUTANT PEDIATRIC T-ALL
Kampen, K.
Girardi, T.
Verbeeck, J.
de Beeck, J. Op
Uyttebroeck, A.
Vermeersch, P.
Moorman, A.
Moorman, A.
Harrison, C.
Meijerink, J.
Geerdens, E.
Cassiman, D.
Cools, J.
De Keersmaecker, K.
HAEMATOLOGICA, 2017, 102 : 26 - 27
[5] THE T-CELL LEUKEMIA ASSOCIATED RIBOSOMAL RPL10 R98S MUTATION ENHANCES JAK-STAT SIGNALING
Girardi, T.
Sulima, S. O.
Vereecke, S.
Khan, Y.
Fancello, L.
Flickinger, Z.
Schwab, C.
de Beeck, J. Op
Verbeeck, J.
Royaert, J.
Geerdens, E.
Vicente, C.
Bornschein, S.
Harrison, C. J.
Meijerink, J. P.
Cools, J.
Dinman, J. D.
Kampen, K. R.
De Keersmaecker, K.
HAEMATOLOGICA, 2017, 102 : 159 - 159
[6] The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling
T Girardi
S Vereecke
S O Sulima
Y Khan
L Fancello
J W Briggs
C Schwab
J Op de Beeck
J Verbeeck
J Royaert
E Geerdens
C Vicente
S Bornschein
C J Harrison
J P Meijerink
J Cools
J D Dinman
K R Kampen
K De Keersmaecker
Leukemia, 2018, 32 : 809 - 819
[7] The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling
Girardi, T.
Vereecke, S.
Sulima, S. O.
Khan, Y.
Fancello, L.
Briggs, J. W.
Schwab, C.
de Beeck, J. Op
Verbeeck, J.
Royaert, J.
Geerdens, E.
Vicente, C.
Bornschein, S.
Harrison, C. J.
Meijerink, J. P.
Cools, J.
Dinman, J. D.
Kampen, K. R.
De Keersmaecker, K.
LEUKEMIA, 2018, 32 (03) : 809 - 819
[8] TRANSLATOME ANALYSIS OF THE T-ALL ASSOCIATED RIBOSOMAL PROTEIN L10 R98S MUTATION REVEALS ALTERED SERINE METABOLISM
Fancello, L.
Kampen, K.
Girardi, T.
de Beeck, J. Op
Verbeeck, J.
Vermeersch, P.
Cassiman, D.
Puch, F. Loayza
Agami, R.
de Keersmaecker, K.
HAEMATOLOGICA, 2017, 102 : 27 - 27

← 1 →